Rare disease research: Breaking the privacy barrier

Area of Science:

• Medical Informatics
• Rare Disease Research
• Bioethics

Background:

• Rare disease research heavily depends on international patient registries for significant output.
• Data sharing from these registries is crucial, and data loss severely impacts research quality.
• Traditional informed consent models and data privacy regulations can hinder effective global data sharing.

Purpose of the Study:

• To explore the tension between patient privacy rights and the need for data sharing in rare disease research.
• To re-evaluate the interpretation of privacy beyond secrecy to include the right to manage one's data.
• To investigate how IT-based informed consent can reconcile individual data control with scientific research needs.

Main Methods:

• Literature review and analysis of existing research on patient consent and data privacy in rare diseases.
• Examination of ethical arguments concerning data sharing versus patient rights.
• Exploration of IT-based informed consent models and their effectiveness.

Main Results:

• Privacy is often narrowly viewed as the right to secrecy, overlooking the right to manage personal data access.
• Traditional consent can be a significant barrier to international rare disease research data sharing.
• IT-based informed consent offers a viable solution to balance data control and research collaboration.

Conclusions:

• A broader understanding of privacy, encompassing data management, is essential for rare disease research.
• Implementing advanced IT-based informed consent can facilitate crucial international data sharing.
• Balancing privacy rights with research imperatives is key to advancing rare disease understanding and treatment.